menu
    • menu

    Company profile for Spur Therapeutics

    NEW Drugs in Dev: 7
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Spur Therapeutics formerly known as Freeline is a privately-held clinical-stage biotechnology company focused on AAV based gene therapy targeting the liver. Our vision is to create better lives for people suffering from chronic systemic diseases using the potential of gene therapy as a one-time curative treatment. Freeline is headquartered in the UK and has operations in Germany and the US.Targeting the liver with our novel ge...
    Spur Therapeutics formerly known as Freeline is a privately-held clinical-stage biotechnology company focused on AAV based gene therapy targeting the liver. Our vision is to create better lives for people suffering from chronic systemic diseases using the potential of gene therapy as a one-time curative treatment. Freeline is headquartered in the UK and has operations in Germany and the US.Targeting the liver with our novel gene therapy platform enables us to treat a wide range of chronic diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Spur Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Stevenage, Herefordshire
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://spurtherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/spurtherapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Spur Therapeutics Unveils FLT201 for Adult Type 1 Gaucher Disease
    Spur Therapeutics Unveils FLT201 for Adult Type 1 Gaucher Disease

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286646/0/en/spur-therapeutics-presents-clinical-insights-on-bone-disease-impact-of-flt201-in-adults-with-gaucher-disease-type-1.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Spur Therapeutics to Present FLT201 Gaucher Data at IWGGD
    Spur Therapeutics to Present FLT201 Gaucher Data at IWGGD

    21 Apr 2026

    // BIOSPACE

    https://www.biospace.com/press-releases/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium

    BIOSPACE
    21 Apr 2026
    Share Share
    Spur Therapeutics Unveils Phase 1/2 Data For Gene Therapy
    Spur Therapeutics Unveils Phase 1/2 Data For Gene Therapy

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231939/0/en/Spur-Therapeutics-Presents-New-Phase-1-2-Data-on-Its-Gene-Therapy-Candidate-in-Gaucher-Disease-at-22nd-Annual-WORLDSymposium.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Spur Therapeutics Showcases FLT201 Data For Gaucher Disease
    Spur Therapeutics Showcases FLT201 Data For Gaucher Disease

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221686/0/en/Spur-Therapeutics-Announces-Platform-and-Poster-Presentations-Highlighting-New-Clinical-Data-for-FLT201-in-Gaucher-Disease-at-Upcoming-WORLDSymposium.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    Spur Therapeutics Unveils Gaucher Disease Gene Therapy Data
    Spur Therapeutics Unveils Gaucher Disease Gene Therapy Data

    07 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/07/3162226/0/en/Spur-Therapeutics-Presents-Updated-Phase-1-2-Data-on-Its-Gene-Therapy-Candidate-in-Gaucher-Disease-at-ESGCT-32nd-Annual-Congress.html

    GLOBENEWSWIRE
    07 Oct 2025
    Share Share
    Spur Therapeutics To Present Gaucher Disease Gene Therapy Data
    Spur Therapeutics To Present Gaucher Disease Gene Therapy Data

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159368/0/en/Spur-Therapeutics-to-Present-New-Clinical-Data-on-Its-Gene-Therapy-Candidate-in-Gaucher-Disease-at-Upcoming-ESGCT-Annual-Congress.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search